NCT06038188Completed
Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey Disease
Effectiveness of a Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey Disease: a Randomized Clinical Trial.
Source: ClinicalTrials.gov · Last updated 28 Mar 2024
Brief summary (registry, in English)
The goal of this clinical trial is to learn about the effect of a booster program aiming to lower daily sitting time (SIT LESS Booster program) compared to usual care in patient with coronary heart problems. The main question it aims to answer is: What is the effect of the SIT LESS Booster on sedentary time and physical activity levels in patient with coronary artery disease who participated in cardiac rehabilitation. Participants will be randomized into 2 groups: 1. Control group who receives usual care; 2. SIT LESS Booster group who receives usual care + a remote 3-week SIT LESS Booster program. Objectively measured changes in daily sitting time from pre- to post SIT LESS Booster will be compared between groups to see if participants in the SIT LESS Booster group are able to reduce daily sedentary time more compared to participants in the control group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 30 Aug 2023
- Start date
- 30 Aug 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Coronary artery disease
- NCT number
- NCT06038188
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 30 Aug 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Coronary arterial bypass graft surgery expected within 8 weeks after inclusion
Other illness
- New York Heart Association class III or IV heart failure
Other
- Unable to give informed consent
- Wheelchair-bounded / not physically able to stand or walk.
- Language barrier
- Participation in another interventional study targeting SB or PA
Who the study is looking for
- Participation in the SIT LESS intervention group of the SIT LESS study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radboudumc Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.